Soft-Tissue Sarcomas in Adults in Ecuador in the Period 2010-2020

Xavier Sánchez; Andrés Moreno Roca; Ruth Jimbo-Sotomayor; Luciana Armijos Acurio; Alfredo Viloria Cestari

doi:10.1155/2022/1391537

Soft-Tissue Sarcomas in Adults in Ecuador in the Period 2010-2020

Sarcoma. 2022 Dec 26:2022:1391537. doi: 10.1155/2022/1391537. eCollection 2022.

Authors

Xavier Sánchez^{1

2}, Andrés Moreno Roca^{1

2

3}, Ruth Jimbo-Sotomayor^{1

2}, Luciana Armijos Acurio^{1

2}, Alfredo Viloria Cestari³

Affiliations

¹ Centro de Investigación Para la Salud en América Latina (CISeAL), Quito, Ecuador.
² Facultad de Medicina, Pontificia Universidad Católica del Ecuador, Quito, Ecuador.
³ Servicio de Cirugía Oncológica, Hospital Carlos Andrade Marín, Quito, Ecuador.

Abstract

Background: Soft-tissue sarcomas (STSs) are rare tumors; they represent 1% of all tumors in adults. There are new diagnostic techniques to differentiate tumor types, and surgery continues to be the most important treatment for STS.

Methods: This cross-sectional study analyzed the morbidity and mortality caused by STS in adults between 2010 and 2020 using national databases.

Results: A total of 8,393 patients hospitalized due to STS were reported. The total number of deaths in Ecuador due to STS was 7,088 over the last decade, the provinces of Pichincha and Guayas registered the highest number of cases, and the mortality rate was 1.2 to 2.0 per 100,000 people. It is noteworthy that the lowest point of registered cases was in 2012.

Conclusion: Soft-tissue sarcomas are rare tumors in Ecuador. The morbidity and mortality caused by these tumors have not changed in the last decade. National studies are needed to determine the prevalence of this illness and study intervention to lower mortality.